Original articles

Pulmonary microcystic fibromyxoma: a case analysis of clinical pathology and review of literature

Expand
  • 1. Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
    2. Department of Radiology, Ruijin Hospital North, Sharghai Jiao Tong University School of Medicine, Shanghai 201801, China

Received date: 2020-05-20

  Online published: 2022-07-15

Abstract

Objective: To investigate the clinical manifestations, pathological features, immunophenotype and diffe-rential diagnosis of pulmonary microcystic fibromyxoma(MFM). Methods: The clinical manifestations, histopathological features, and immunophenotype were analyzed retrospectively in a patient diagnosed as pulmonary MFM, and the related literature was reviewed. Results: A 63-year-old man was detected to have lung nodule located in upper left lobe by routine X-ray examination. The chest CT showed multiple nodules in different sizes and the largest one located in the upper left lobe with smooth borders and mild enhancement. The resection of left upper lobe in lung was performed for the patient. Grossly,the big tumor located close to the edge of the lobe and the size was about 1.5 cm×1.1 cm×0.7 cm. It was grayish red, soft and had relatively clear border. Microscopically, the tumor had clear edge, and extensive microcapsule structures were observed. The cell showed the shapes of spindle or stellate without cellular atypia or mitotic figures. The tissue had a lot myxoid stroma, abundant small blood vessels and scattered lymphocytes, plasma cells,mast cells and macrophages. The other small tumor (maximum diameter of 0.2 cm) with similar morphology was 0.2 cm away from the larger one. Its' immunophenotype showed that the tumor cells were diffuse vimentin positive, and Ki-67 labelling index was low(<1%). The immunohistochemical markers for epithelial cells, muscle cells, nerve cells, neuroendocrine cells, vascular endothelial cells, and mesothelial cells were all negative. The chromosome translocation was not observed in EWSR1 gene by fluorescence in situ hybridization. The chest CT scans of the patient were repeated 12 and 18 months post the surgery and showed the number and size of multiple small nodules in right lung increased slightly. Conclusions: Pulmonary MFM is a rare mesenchymal tumor, and histologic structure is characterized with presence of microcapsule and myxoid stroma, and the tumor cells were vimentin positive. The diagnosis of pulmonary MFM depends on the morphologic observation and immunohistochemical staining. So far, the recurrence or metastasis has not been reportedyet, however, the imaging follow-up of this case shows the nodules slightly increased in numbers and size, which suggests that pulmonary MFM may have malignant potential.

Cite this article

XU Haimin, CHEN Xiaoyan, ZHANG Jing, YANG Xiaoqun, WANG Chaofu . Pulmonary microcystic fibromyxoma: a case analysis of clinical pathology and review of literature[J]. Journal of Diagnostics Concepts & Practice, 2020 , 19(04) : 381 -385 . DOI: 10.16150/j.1671-2870.2020.04.011

References

[1] Shilo K, Miettinen M, Travis WD, et al. Pulmonary microcystic fibromyxoma: report of 3 cases[J]. Am J Surg Pathol, 2006, 30(11):1432-1435.
[2] Ahn J, Kim NR, Ha SY, et al. A case of primary subpleural pulmonary microcystic myxoma coincidentally occurred with pulmonary adenocarcinoma[J]. J Pathol Transl Med, 2015, 49(3):274-278.
[3] 贡其星, 李海, 张智弘, 等. 肺微囊性纤维黏液瘤的临床病理学特征[J]. 中华病理学杂志, 2018, 47(2):110-113.
[4] 魏建国, 王强, 张仁亚, 等. 新近认识具有黏液样特征的少见肺部肿瘤的临床病理学特征[J]. 中华病理学杂志, 2017, 46(5):352-356.
[5] Travis WD, Brambilla E, Burke AP, et al. WHO classification of tumours of the lung, pleura, thymus and heart[M]. Lyon:IARC: 2015.
[6] Thway K, Nicholson AG, Lawson K, et al. Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a new tumor entity[J]. Am J Surg Pathol, 2011, 35(11):1722-1732.
[7] Tsuta K, Kalhor N, Wistuba II, et al. Clinicopathological and immunohistochemical analysis of spindle-cell carcinoid tumour of the lung[J]. Histopathology, 2011, 59(3):526-536.
[8] Nannini N, Bertolini F, Cavazza A, et al. Atypical carcinoid with prominent mucinous stroma: a hitherto unreported variant of pulmonary neuroendocrine tumor[J]. Endocr Pathol, 2010, 21(2):120-124.
[9] Fracasso T, Varchmin-Schultheiss K. Sudden death due to pulmonary embolism from right atrial myxoma[J]. Int J Legal Med, 2009, 123(2):157-159.
[10] Geng J, Cao B, Wang L. Aggressive angiomyxoma: an unusual presentation[J]. Korean J Radiol, 2012, 13(1):90-93.
[11] Kalebi AY, Hale MJ. Pulmonary metastasis from a deltoid subcutaneous low-grade fibromyxoid sarcoma with giant collagen rosettes[J]. Hum Pathol, 2008, 39(10):1553-1554.
[12] Tsuchie H, Kaya M, Nagasawa H, et al. Distant metastasis in patients with myxofibrosarcoma[J]. Ups J Med Sci, 2017, 122(3):190-193.
[13] Kapoor N, Shinagare AB, Jagannathan JP, et al. Clinical and radiologic features of extraskeletal myxoid chondrosarcoma including initial presentation, local recurrence, and metastases[J]. Radiol Oncol, 2014, 48(3):235-242.
[14] D'Ambrosio FG, Shiu MH, Brennan MF. Intrapulmonary presentation of extraskeletal myxoid chondrosarcoma of the extremity. Report of two cases[J]. Cancer, 1986, 58(5):1144-1148.
[15] Nicolas M, Moran CA, Suster S. Pulmonary metastasis from liposarcoma: a clinicopathologic and immunohistochemical study of 24 cases[J]. Am J Clin Pathol, 2005, 123(2):265-275.
[16] Choi YD, Kim JH, Nam JH, et al. Aggressive angiomyxoma of the lung[J]. J Clin Pathol, 2008, 61(8):962-964.
[17] Balanzá R, Arrangoiz R, Cordera F, et al. Pulmonary extraskeletal myxoid chondrosarcoma: a case report and lite-rature review[J]. Int J Surg Case Rep, 2016, 27:96-101.
[18] 刘有, 张晓欢, 宋志刚, 等. 肺原发性骨外黏液样软骨肉瘤临床病理观察[J]. 诊断病理学杂志, 2019, 26(8):523-527.
Outlines

/